Operational Costs Compared: SG&A Analysis of Lantheus Holdings, Inc. and HUTCHMED (China) Limited

SG&A Expenses: Lantheus vs. HUTCHMED Over a Decade

__timestampHUTCHMED (China) LimitedLantheus Holdings, Inc.
Wednesday, January 1, 20142668400072429000
Thursday, January 1, 20152982900078634000
Friday, January 1, 20163957800075374000
Sunday, January 1, 20174327700092157000
Monday, January 1, 20184864500093326000
Tuesday, January 1, 201952934000103132000
Wednesday, January 1, 202061349000110171000
Friday, January 1, 2021127125000218817000
Saturday, January 1, 2022136106000233827000
Sunday, January 1, 2023133175999267194000
Loading chart...

Data in motion

A Decade of SG&A: Lantheus Holdings vs. HUTCHMED

In the ever-evolving landscape of healthcare, operational efficiency is paramount. Over the past decade, Lantheus Holdings, Inc. and HUTCHMED (China) Limited have demonstrated contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses.

Lantheus Holdings, Inc.

From 2014 to 2023, Lantheus Holdings saw a remarkable 270% increase in SG&A expenses, peaking at approximately $267 million in 2023. This growth reflects the company's aggressive expansion and strategic investments in operational capabilities.

HUTCHMED (China) Limited

Conversely, HUTCHMED's SG&A expenses grew by nearly 400% over the same period, reaching around $133 million in 2023. This surge underscores HUTCHMED's commitment to scaling its operations and enhancing its market presence.

Conclusion

These trends highlight the dynamic nature of the healthcare sector, where strategic investments in operational costs can significantly impact a company's competitive edge.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025